Skip to Content


Recent study on drug for newly diagnosed glioblastoma patients

Cancer Newsline - 06/03/2013

Bevacizumab offers no benefit for newly diagnosed glioblastoma (brain) cancer patients, MD Anderson-led study finds. Mark Gilbert, M.D., professor in Neuro-Oncology at MD Anderson Cancer Center, and Minesh Mehta, M.D., Ph.D., chairman of Radiation Oncology at the University of Maryland School of Medicine, discuss their study in the front line setting for the treatment of glioblastoma.  

Guests: Mark Gilbert, M.D. and Minesh Mehta, M.D., Ph.D.

Request an Appointment U.S. News & World Report badge

Subscribe to Cancer Newsline

Subscribe to Cancer 
Newsline on iTunesU

What is iTunesU?iTunesU is a part of the iTunes Store that features free podcasts, lectures and other educational content that you can download to your Mac or PC, iPhone, iPod, or other portable device. 

Sign up to receive Cancer Newsline in your RSS Feed.


Study for newly diagnosed glioblastoma (brain) cancer using Bevacizumab.

© 2015 The University of Texas MD Anderson Cancer Center